SONA — Sona Nanotech Income Statement
0.000.00%
Last trade - 00:00- CA$32.40m
- CA$31.36m
Annual income statement for Sona Nanotech, fiscal year end - October 31st, CAD millions except per share, conversion factor applied.
2020 October 31st | 2021 October 31st | 2022 October 31st | 2023 October 31st | 2024 October 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 6.01 | 10.7 | 2.73 | 2.62 | 2.92 |
| Operating Profit | -6.01 | -10.7 | -2.73 | -2.62 | -2.92 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -6.27 | -10.4 | -2.36 | -2.5 | -2.7 |
| Net Income After Taxes | -6.27 | -10.4 | -2.36 | -2.5 | -2.7 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -6.27 | -10.4 | -2.36 | -2.5 | -2.7 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -6.27 | -10.4 | -2.36 | -2.5 | -2.7 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.157 | -0.162 | -0.044 | -0.032 | -0.027 |